![]() |
市場調査レポート
商品コード
980464
心血管インターベンション用デバイス市場:洞察、競合情勢および2025年までの予測Interventional Cardiology Devices Market Insights, Competitive Landscape and Market Forecast-2025 |
心血管インターベンション用デバイス市場:洞察、競合情勢および2025年までの予測 |
出版日: 受注生産
発行: DelveInsight Business Research LLP
ページ情報: 英文 120 Pages
納期: 約10営業日
|
心血管インターベンション用デバイス市場は、低侵襲手術への選好の高まり、心血管疾患の有病率増加、技術の進歩などにより、成長が推進されています。ただし、デバイスの調達と使用に関連する高いコストは、市場成長の妨げとなっています。
当レポートは、世界主要7ヶ国(米国、欧州5ヶ国(ドイツ、スペイン、フランス、イタリア、英国)および日本)の 市場について調査しており、市場規模および予測、成長要因および障壁、製品プロファイル、KOLの見解、競合情勢、主要企業のプロファイルなどの情報を提供しています。
当レポート掲載の企業リスト:
Boston Scientific Corporation(米国)、Abbott Laboratories(米国)、Medtronic Public Limited Company(米国)、Cordis Corporation(米国)、Terumo Corporation(日本)、B .Braun、CR Bard(米国)、Biosensors(シンガポール)、Ivascular(スペイン)、BIOTRONIK(ドイツ)
DelveInsight's 'Interventional Cardiology Devices-Market Insights, Competitive Landscape and Market Forecast - 2025' report delivers an in-depth understanding of Interventional Cardiology Devices and the historical and forecasted Interventional Cardiology Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Interventional Cardiology Devices market report provides an overview of Interventional Cardiology Devices, reasons to get Interventional Cardiology Devices as well as its advantages and limitations. Additionally, the report provides insight on the Interventional Cardiology Devices market share of the individual Interventional Cardiology Devices devices, current and forecasted Interventional Cardiology Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Interventional Cardiology Devices Overview
Interventional Cardiology devices are used in the diagnosis and treatment of patients suffering from cardiovascular diseases. Rising preference for minimally- invasive surgeries, incresing prevalence of cardiovascular diseases and technological advancements in this field are the driving factors for market growth. High costs associated with the procurement and use of devices are restricting the intervention cardiology devices and equipment market.
Study Period: 2017-2025
List of Companies:
Boston Scientific Corporation (Boston Scientific) (US), Abbott Laboratories (Abbott) (US), Medtronic Public Limited Company (Medtronic) (US), Cordis Corporation (Cordis) (US), Terumo Corporation (Terumo) (Japan), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), Ivascular (Spain) and BIOTRONIK (Germany)
Interventional Cardiology Devices- Competitive Analysis
This segment of the report provides a brief competitive analysis of Interventional Cardiology Devices, to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.
Interventional Cardiology Devices: Market Analysis
This segment illustrates the market of Interventional Cardiology Devices across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
KOL- Views
To keep up with the market trends, we take KOLs and SME's opinion working in Interventional Cardiology Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Interventional Cardiology Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Market Insights:
Competitive Landscape:
4.2.1.Company Overview
Products detail in the report…
6.1.1. Interventional Cardiology Devices: Market Analysis in the 7MM by type (2017-2025)
6.1.2. Interventional Cardiology Devices: Market Analysis in the 7MM by application (2017-2025)
6.1.3. Interventional Cardiology Devices: Market Analysis in the 7MM by end user (2017-2025)
6.2.1. Interventional Cardiology Devices: Market Analysis in the US by type (2017-2025)
6.2.2. Interventional Cardiology Devices: Market Analysis in the US by application (2017-2025)
6.2.3. Interventional Cardiology Devices: Market Analysis in the US by end user (2017-2025)
6.3.1. Interventional Cardiology Devices: Market Analysis in Germany by type (2017-2025)
6.3.2. Interventional Cardiology Devices: Market Analysis in Germany by application (2017-2025)
6.3.3. Interventional Cardiology Devices: Market Analysis in Germany by end user (2017-2025)
6.3.1. Interventional Cardiology Devices: Market Analysis in France by type (2017-2025)
6.3.2. Interventional Cardiology Devices: Market Analysis in France by application (2017-2025)
6.3.3. Interventional Cardiology Devices: Market Analysis in France by end user (2017-2025)
6.5.1. Interventional Cardiology Devices: Market Analysis in Italy by type (2017-2025)
6.5.2. Interventional Cardiology Devices: Market Analysis in Italy by application (2017-2025)
6.5.3. Interventional Cardiology Devices: Market Analysis in Italy by end user (2017-2025)
6.6.1. Interventional Cardiology Devices: Market Analysis in Spain by type (2017-2025)
6.6.2. Interventional Cardiology Devices: Market Analysis in Spain by application (2017-2025)
6.6.3. Interventional Cardiology Devices: Market Analysis in Spain by end user (2017-2025)
6.7.1. Interventional Cardiology Devices: Market Analysis in the UK by type (2017-2025)
6.7.2. Interventional Cardiology Devices: Market Analysis in the UK by application (2017-2025)
6.7.3. Interventional Cardiology Devices: Market Analysis in the UK by end user (2017-2025)
6.8.1. Interventional Cardiology Devices: Market Analysis in Japan by type (2017-2025)
6.8.2. Interventional Cardiology Devices: Market Analysis in Japan by application (2017-2025)
6.8.3. Interventional Cardiology Devices: Market Analysis in Japan by end user (2017-2025)